Home
Syntara (ASX:SNT) - Webinar Presentation
PUBLISHED
2024-05-17
Content
Gary Phillips - CEO - Syntara (ASX:SNT) is a clinical-stage drug development company working to bring new and life-changing treatments to patients in need. The company has ongoing trials in myelofibrosis, myelodysplastic syndrome, scar prevention, modifcation of existing scars, isolated REM sleep behaviours disorder and Parkinson's Disease.
Author
Name | Finance News Network |